If you need more lookups,
subscriptions start at $34 USD/month.
Uwe Meya Location
Basel, BS, CH
Uwe Meya Work
2024 -now Chief Medical Officer @
2021 -now Semi Retired @ Continuing p
2021 -now Semi Retired @ Continuing on Clinical Development CNS (neurodegenerative and rare diseases)
2022 -2025 Chief Medical Officer @ GliaPharm SA, Geneva
2016 -2022 Chief Medical Officer @ Minoryx Therapeutics S.L.
2015 -2016 Vice President International Clinical Development @
2007 -2015 Vice President Clinical Development @
2005 -2007 Head Research Portfolio Management @
2001 -2004 Leader, Neuroscience Disease Area Strategy Team @
1999 -2004 Clinical Research and Licensing Liaison Manager CNS @
1996 -1999 Head of Therapeutic Area Nervous System, Clinical Research (Europe) @
1995 -1996 Head of International Clinical Reseach CNS (Europe) @
1993 -1995 Head of Clincal Development CNS (Europe) @ Knoll AG
1986 -1992 Medical Advisor and Head of Clinical Psychiatry (Europe) @ Schering AG Berlin
Uwe Meya Education
Freie Universität Berlin
Clinical Psychiatrist (Psychiatry)
1983-1986
RWTH Aachen University
Clinical Neurologist (Neurology)
1980-1983
RWTH Aachen University
Staatsexamen (Medicine)
1973-1980
Uwe Meya Skills
Biowissenschaften
Uwe Meya Summary
Uwe Meya, based in Basel, BS, CH, is currently a Chief Medical Officer at SynaptixBio Ltd.. Uwe Meya brings experience from previous roles at Continuing p, Continuing on Clinical Development CNS (neurodegenerative and rare diseases), GliaPharm SA, Geneva and Minoryx Therapeutics S.L.. Uwe Meya holds a 1983 - 1986 Clinical Psychiatrist in Psychiatry @ Freie Universität Berlin. With a robust skill set that includes Biowissenschaften and more. Uwe Meya has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Uwe Meya?
Find contact details for 700 million professionals.